New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 11, 2018 - The FDA announced the approval of Exela’s Glyrx-PF (glycopyrrolate), for adult and pediatric patients in anesthesia and for adult patients in peptic ulcer.
Download PDF
Return to publications
